Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
MI-2
i
Other names:
MI-2
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Trials
Company:
University of Michigan
Drug class:
Menin-MLL inhibitor
Related drugs:
‹
revumenib (18)
KO-539 (13)
BMF-219 (10)
VTP-50469 (5)
MI-503 (4)
DS-1594 (3)
D0060-319 (1)
DSP-5336 (1)
DS-M1 (0)
revumenib (18)
KO-539 (13)
BMF-219 (10)
VTP-50469 (5)
MI-503 (4)
DS-1594 (3)
D0060-319 (1)
DSP-5336 (1)
DS-M1 (0)
›
Associations
(1)
News
Trials
VERI cancer hierarchy
Reset Filters
BIRC3‐MALT1 fusion
Lymphoma
BIRC3‐MALT1 fusion
Lymphoma
MI-2
Sensitive: D – Preclinical
MI-2
Sensitive
:
D
MI-2
Sensitive: D – Preclinical
MI-2
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login